Cleared Traditional

K940003 - VOLUMET CD4 + AND CD8 + T LYMPHOCYTE COUNT TEST KIT

K940003 is an FDA 510(k) clearance for VOLUMET CD4 + AND CD8 + T LYMPHOCYTE CO..., manufactured by Buckman Co., Inc.. The device is a Class 2 Hematology device with product code GKZ cleared through the Traditional 510(k) pathway after a 654-day FDA review.

K940003 · Buckman Co., Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1995
Decision
654d
Days
Class 2
Risk

K940003 is an FDA 510(k) clearance for the VOLUMET CD4 + AND CD8 + T LYMPHOCYTE COUNT TEST KIT. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Buckman Co., Inc. (Concord, US). The FDA issued a Cleared decision on October 19, 1995 after a review of 654 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Hematology submissions.

View all Buckman Co., Inc. devices

FDA 510(k) Submission Details - K940003

510(k) Number K940003 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 1994
Decision Date October 19, 1995
Days to Decision 654 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
541d slower than avg
Panel avg: 113d · This submission: 654d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 309
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K940003.
IMAGN(TM) 2000 SYSTEM
K945756 · Buckman Co., Inc. · Dec 1995
FACS LOADER SYSTEM
K953302 · Becton Dickinson Immunocytometry Systems · Nov 1995
OPTICLONE IGG1 FITC/IGG2A PE ISOTYPIC CONTROL
K954188 · Immunotech Corp. · Nov 1995
CELL-DYN 3500 MULTI-PARAMETER AUTOMATED HEMATOLOGY ANALYZER
K951496 · Abbott Laboratories · Oct 1995
ROCHE COBAS MICROS HEMATOLOGY ANALYZER
K953448 · Roche Diagnostic Systems, Inc. · Oct 1995
CYTO-STAT/COULTER CLONE CD3-ECD/T4-RD1/T8-FITC MONOCLONAL ANTIBOEY REAGENT
K950742 · Coulter Corp. · Aug 1995